Medical Condition News

RSS

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

To be published online Monday, Dec. 2, a special issue of the Journal of the American College of Radiology addresses imaging-based screening and radiology's increasing role in preventive medicine. Topics covered include breast density legislation, digital breast tomosynthesis (or 3-D mammography), lung cancer screening and computed tomography colonography reimbursement.

2 Dec 2013

PRP therapy improves functionality of tendons in athletes with degenerative disease

Ultrasound-guided delivery of platelet-rich plasma improves functionality and reduces recovery time in athletes with degenerative disease in their tendons, according to a study being presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

Stroke patients report improvements in their motor function using novel rehabilitation device

Using a novel stroke rehabilitation device that converts an individual's thoughts to electrical impulses to move upper extremities, stroke patients reported improvements in their motor function and ability to perform activities of daily living. Results of the study were presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

MRI provides noninvasive way to measure iron levels in the brains of ADHD people

Magnetic resonance imaging provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder, according to a study being presented today at the annual meeting of the Radiological Society of North America. Researchers said the method could help physicians and parents make better informed decisions about medication.

2 Dec 2013

Soldiers who suffer blast-induced MTBI exhibit long-term brain differences

Using a special type of magnetic resonance imaging, researchers have found that soldiers who suffered mild traumatic brain injury induced by blast exposure exhibit long-term brain differences, according to a study being presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

Study reveals effect of energy drinks on the function of the heart

Healthy adults who consumed energy drinks high in caffeine and taurine had significantly increased heart contraction rates one hour later, according to a study presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

World-class Krembil Discovery Tower now opens in Canada

The Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women congratulated Toronto Western Hospital today on the opening of the Krembil Discovery Tower, a facility dedicated to research excellence, training the next generation of medical professionals and improving health care for patients across Canada.

2 Dec 2013

Scientists transform human stem cells into functional lung and airway cells

For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway cells. The advance, reported by Columbia University Medical Center researchers, has significant potential for modeling lung disease, screening drugs, studying human lung development, and, ultimately, generating lung tissue for transplantation.

2 Dec 2013

Researchers discover promising new approach for colorectal cancer treatment

Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.

2 Dec 2013

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

People living with chronic fatigue are set to benefit with the opening next week (Dec 2), of the National Centre for Neuroimmunology and Emerging Diseases at Griffith University.

30 Nov 2013

Social networking sites have positive effects on people with eating disorders

Social networking sites, such as Instagram have traditionally been believed to have a negative effect on people with eating disorders, but new research from Griffith’s School of Public Health has found that may not be the case.

30 Nov 2013

Garden-Gateway believes chronic sufferers can cope with holiday stress

The holidays are a time of high stress for all of us. This is especially true for the many Californians who suffer from chronic illness or disease. It's well documented that stress can aggravate a wide range of chronic ailments, both physical and psychological, such as back pain, cancer, PTSD or immune system deficiency.

30 Nov 2013

EAUN launches new online course on bone health and urological cancer

The European Association of Urology Nurses launched a new online course for urology nurses and affiliated professionals "Bone health and urological cancer". This course tackles a highly pressing issue of maintaining and promoting bone health in cancer patients.

29 Nov 2013

Patrys to present data from PAT-SM6 Phase I/IIa trial in multiple myeloma at ASH conference

Patrys Limited (ASX: PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.

29 Nov 2013

Ascend, 3M partner to develop and evaluate novel immunotherapy treatments for cancer

Ascend Biopharmaceuticals today announces that is has entered into an agreement with 3M Drug Delivery Systems to evaluate 3M’s Toll-Like Receptor 7/8 (TLR7/8) agonist 3M-051 in combination with Ascend’s proprietary cancer vaccine technology. The collaboration will support the creation and preclinical assessment of novel immunotherapy treatments to be potentially used for a number of different solid tumor types.

29 Nov 2013

Data from Patrys' PAT-SM6 Phase I/IIa trial in multiple myeloma to be presented at ASH Annual Meeting

Patrys Limited, a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.

29 Nov 2013

Study reveals new mechanism that may block formation of new blood vessels and cancer growth

A study led by researchers at Boston University School of Medicine demonstrates a new mechanism involving a signaling protein and its receptor that may block the formation of new blood vessels and cancer growth. The findings are published in the December issue of Science Signaling.

29 Nov 2013

Sumitomo receives FDA 510(k) clearance for Proton Therapy System

Sumitomo Heavy Industries, Ltd. announced today that it had received US FDA 510(k) clearance of its Proton Therapy System. It is the first 510(k) cleared medical device for Sumitomo. Proton therapy is a form of radiation therapy, which employs proton beams to kill cancer cells with better dose distribution in comparison with conventional x-rays. Currently 12 facilities are operational and several more are under construction in the United States, and the U.S. proton therapy market is expected to expand in the future.

29 Nov 2013

Researchers identify gene responsible for malfunctions in fear-related memory system

A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.

29 Nov 2013

Medical Condition News

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

PRP therapy improves functionality of tendons in athletes with degenerative disease

Stroke patients report improvements in their motor function using novel rehabilitation device

MRI provides noninvasive way to measure iron levels in the brains of ADHD people

Soldiers who suffer blast-induced MTBI exhibit long-term brain differences

Study reveals effect of energy drinks on the function of the heart

World-class Krembil Discovery Tower now opens in Canada

Scientists transform human stem cells into functional lung and airway cells

Researchers discover promising new approach for colorectal cancer treatment

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

Social networking sites have positive effects on people with eating disorders

Garden-Gateway believes chronic sufferers can cope with holiday stress

EAUN launches new online course on bone health and urological cancer

Patrys to present data from PAT-SM6 Phase I/IIa trial in multiple myeloma at ASH conference

Ascend, 3M partner to develop and evaluate novel immunotherapy treatments for cancer

Data from Patrys' PAT-SM6 Phase I/IIa trial in multiple myeloma to be presented at ASH Annual Meeting

Study reveals new mechanism that may block formation of new blood vessels and cancer growth

Sumitomo receives FDA 510(k) clearance for Proton Therapy System

Researchers identify gene responsible for malfunctions in fear-related memory system

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News